Processa Pharmaceuticals Inc

NASDAQ:PCSA   3:59:50 PM EDT
4.72
+0.15 (+3.28%)
Earnings Announcements

Processa Pharmaceuticals Posts Q3 Loss Per Share Of $0.19

Published: 11/11/2021 22:13 GMT
Processa Pharmaceuticals Inc (PCSA) - Processa Pharmaceuticals Announces Third Quarter 2021 Results and Provides Corporate Update.
Q3 Loss per Share $0.19.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.